Medications and Deprescribing Series (Presentation 1/6): Polypharmacy and Deprescribing



Date & Location
Wednesday, July 8, 2020, 12:05 AM - Thursday, July 7, 2022, 11:00 PM

Overview

The Medications and Deprescribing Series is sponsored by the Iowa Geriatric Education Center (IGEC), which is supported by the Iowa Geriatrics Workforce Enhancement Program (Iowa-GWEP) through the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS). Click here to go to the IGEC Homepage

There is a growing awareness of the impact of polypharmacy on the older adult. This series of six presentations is designed to provide healthcare professionals with training in the context of medication management, with the goal to advance the reach of geriatric expertise and ultimately improve care for patients and their families.

This series will be of particular interest to all health professionals who interact with older adult patients.

Presentations in the Medications and Deprescribing Series

Though completion of the entire series is not required to earn credit for individual presentations, it is strongly recommended, and the presentations are designed to be completed in order.

  1. Polypharmacy and Deprescribing
  2. Kidney Function and Medication Dosing Adjustments in the Older Adult
  3. High Risk Medications: Balancing the Risks and Benefits when Deprescribing
  4. Deprescribing and Alternative Treatments to Opioids and Anti-Anxiety Medications in Older Adults
  5. Reducing Risk of Negative Health Outcomes; Immunizations and Beers Criteria Update
  6. Deprescribing Antipsychotics in Older Adults

In Polypharmacy and Deprescribing, Dr. Swegle will describe the importance of polypharmacy and the effects it has on patients. Dr. Swegle will also identify the various tools available to help reduce polypharmacy. Finally, he will describe an approach to facilitate Deprescribing and strategies for reducing unnecessary medications in the older adult.


Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Target Audience
Professions - Fellow, Nurse, Nurse Practitioner, Physician, Physician Assistant, Resident, Student, Technician

Objectives
  1. Recognize the importance of polypharmacy and the effects it has on patients.
  2. Evaluate the various tools available to help reduce polypharmacy.
  3. Design and approach to facilitate Deprescribing.
  4. Apply different approaches for reducing unnecessary medications in the older adult.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Iowa Roy J. and Lucille A. Carver College of Medicine and the Iowa Geriatric Education Center, College of Nursing. The Carver College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CME Credit Designation
The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
As of March 18, 2020, Iowa nurses may use participation in ACCME-accredited education toward their CE requirement for licensure. A certificate of participation will be available after successful completion of the course. Please review the Iowa Board of Nursing's website for more information. (Nurses from other states should confirm with their licensing boards that this activity meets their state's licensing requirements.)

IBON What CE Qualifies?

IBON Appropriate Subject Matter

Disclosure Policy
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest.

Financial Disclosures
Planners and faculty disclosed no relevant financial relationships with ACCME-defined commercial interests.